SEC Filing Summary: Know Labs, Inc. (KNW)
Business Context and Reporting Period
This Form 8-K was filed by Know Labs, Inc. on October 22, 2024. The report details a material definitive agreement regarding the company's debt obligations. The registrant is incorporated in Nevada and trades on the NYSE American LLC under the symbol KNW.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or liquidity metrics. The only financial data disclosed relates to specific debt terms:
- Debt Instrument: Senior Secured Convertible Redeemable Notes.
- Lenders: Ronald P. Erickson and/or affiliated entities (specifically J3E2A2Z LP).
- Interest Rate Change: Increased from 6% to 8%.
- Maturity Extension: Due date extended from September 30, 2024, to September 30, 2025.
Material Changes
The primary material change is the amendment of existing convertible promissory notes dated January 31, 2018. The amendments, executed on October 22, 2024, defer the repayment obligation by one year and increase the cost of borrowing by 200 basis points.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the implications of the debt amendment. The extension of the debt maturity suggests a need to manage short-term liquidity, while the interest rate increase reflects the cost of that extension.
Investor Verification Checklist
- Verify the total principal amount outstanding on the notes held by Ronald P. Erickson and J3E2A2Z LP.
- Confirm the conversion terms of the notes to assess potential dilution.
- Review the company's most recent 10-Q or 10-K to understand the broader liquidity context necessitating this extension.
- Check for any other related party transactions involving Ronald P. Erickson.